5004052026-04-012026-06-305004052026-04-012026-06-30in-capmkt:OtherExpenses1Member5004052026-04-012026-06-30ItemsThatWillNotBeReclassifiedToProfitAndLoss1iso4217:INRiso4217:INRxbrli:shares500405SPLPETRONOTLISTEDINE663A01033SUPREME PETROCHEM LIMITEDMain BoardEquity2026-04-012027-03-312026-07-272026-07-20INRLakhsQuarterlyFirst quarterSingle segmentThe Group operates in Styrenics and Allied Products which in the context of Ind AS-108 Operating Segments constitutes a single reportable business segment.2026-07-2715:30:002026-07-2716:25:00Not applicablefalsefalseNot Applicable2026-04-012026-06-30UnauditedStandalone1692707800017396700017101045000104218760003441897000-12158880002015610003403900027664600077216900013932300000316874500003168745000788800000166020008054020000236334300000002363343000-37020002359641000376083000212.5712.570012.5712.571. The above Statement of Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026 (" Financial Results") comprising of the financial results of the parent Company and its subsidiary Xmold Polymers Pvt Ltd ("Xmold") (together referred to as Group) have been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" (Ind AS-34) as prescribed under Section 133 of the Companies Act, 2013 ("the Act"), read with the relevant rules thereunder. <br /> <br /> 2. These Financial Results have been reviewed by the Audit Committee and approved by the Board of Directors of Company at their respective meetings held on July 27, 2026. The Statutory Auditor of the Company has conducted a limited review of the Financial Results for the quarter ended June 30, 2026 and have expressed an unmodified conclusion on the Financial Results. These Financial Results have been prepared and published in accordance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. <br /> <br /> 3.The financial figures for the quarter ended March 31, 2026, are the balancing figures between audited figures in respect of the full financial year and the published reviewed year-to-date figures upto the end of the third quarter for the financial year ended March 31, 2026. <br /> <br /> 4. The Group operates in 'Styrenics and Allied Products' which in terms of Ind AS-108 "Operating Segments" constitutes a single reportable business segment. <br /> <br /> 5. Finance cost comprises majorly of interest expenses on lease in terms of Ind AS 116- Leases. The Company continues to remain debt free. <br /> <br /> 6. The Company does not have any joint venture or associate falling within the requisite control parameters as defined in Ind AS, as on June 30, 2026. <br /> <br /> OTHER EXPENSES772169000Remeasurement of the defined benefit plans-4947000-4947000-1245000-3702000